SCHEMBL20358014

SCHEMBL20358014

CN(C)c1ccc(C=C2CCOC2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
KMT2A Q03164 4/20 0.64
DYRK1A Q13627 6/20 0.63
DYRK1B Q9Y463 6/20 0.63
MAPT P10636 4/20 0.63
CYP1A2 P05177 1/20 0.59
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
HPGD P15428 1/20 0.58
MEN1 O00255 3/20 0.57
LMNA P02545 2/20 0.57
DYRK2 Q92630 3/20 0.55
MAOB P27338 2/20 0.55
CLK1 P49759 2/20 0.52
MAPK1 P28482 1/20 0.52
MCOLN3 Q8TDD5 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NSD2 O96028 1/20 0.51
MAOA P21397 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17147752 1.00 ALDH1A1 (0.65) ALDH1A1KMT2ADYRK1ADYRK1BMAPT
SCHEMBL981190 0.79 ALDH1A1 (1.00) ALDH1A1KMT2ADYRK1ADYRK1BMAPT
SCHEMBL3526528 0.79 ALDH1A1 (1.00) ALDH1A1KMT2ADYRK1ADYRK1BMAPT
SCHEMBL9490046 0.78 KMT2A (1.00) ALDH1A1KMT2ADYRK1ADYRK1BMAPT
SCHEMBL2869244 0.78 CYP1A2 (0.86) ALDH1A1KMT2AMAPTCYP1A2NPC1
SCHEMBL2868624 0.78 CYP1A2 (0.86) ALDH1A1KMT2AMAPTCYP1A2NPC1
SCHEMBL11966165 0.78 CYP1A2 (0.86) ALDH1A1KMT2AMAPTCYP1A2NPC1
SCHEMBL29099913 0.78 CYP1A2 (0.86) ALDH1A1KMT2AMAPTCYP1A2NPC1
SCHEMBL9566863 0.77 DYRK1A (1.00) ALDH1A1KMT2ADYRK1ADYRK1BMAPT
SCHEMBL27260229 0.77 DYRK1A (1.00) ALDH1A1KMT2ADYRK1ADYRK1BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells NORTHEAST NORMAL UNIVERSITY (CN) 2020-07-28 US claimed
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS NORTHEAST NORMAL UNIVERSITY (CN) 2018-07-12 US claimed
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells NORTHEAST NORMAL UNIVERSITY (CN) 2020-07-28 US disclosed
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS NORTHEAST NORMAL UNIVERSITY (CN) 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS XPA, MEP1A, EED ALDH1A1 107/4885KMT2A 1689/4885DYRK1A 4669/4885
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells XPA, MEP1A, EED ALDH1A1 107/4885KMT2A 1689/4885DYRK1A 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.